[1]刘紫薇,刘市委,雷 磊,等.基于Web of Science关于肾癌预后研究的文献计量分析[J].医学信息,2022,35(15):14-19.[doi:10.3969/j.issn.1006-1959.2022.15.003]
　LIU Zi-wei,LIU Shi-wei,LEI Lei,et al.Bibliometric Analysis of Renal Cell Carcinoma Prognosis Based on Web of Science[J].Journal of Medical Information,2022,35(15):14-19.[doi:10.3969/j.issn.1006-1959.2022.15.003]
点击复制

基于Web of Science关于肾癌预后研究的文献计量分析()
分享到：

医学信息[ISSN:1006-1959/CN:61-1278/R]

卷:
35卷
期数:
2022年15期
页码:
14-19
栏目:
医学数据科学
出版日期:
2022-08-01

文章信息/Info

Title:
Bibliometric Analysis of Renal Cell Carcinoma Prognosis Based on Web of Science
文章编号:
1006-1959（2022）15-0014-06
作者:
刘紫薇; 刘市委; 雷 磊; 等
（1.中国医科大学公共卫生学院，辽宁 沈阳 110122；2.广东省人民医院/广东省医学科学院，广东 广州 510080）
Author(s):
LIU Zi-wei; LIU Shi-wei; LEI Lei; et al.
(1.School of Public Health,China Medical University,Shenyang 110122,Liaoning,China;2.Guangdong Provincial People’s Hospital/Guangdong Academy of Medical Sciences,Guangzhou 510080,Guangdong,China)
关键词:
肾癌; 甲基化驱动基因; C反应蛋白; 高频关键词
Keywords:
Renal cell carcinoma; Methylation-driven genes; C-reactive protein; High frequency keywords
分类号:
R737.11
DOI:
10.3969/j.issn.1006-1959.2022.15.003
文献标志码:
A
摘要:
目的 通过文献计量学方法分析近10年肾癌预后研究领域文献分布规律和发展态势。方法 在Web of Science核心合集数据库检索2011-2021年肾癌预后研究领域相关文献，利用CiteSpace5.8.R1对论文数量、国家分布、研究主题和高频关键词等进行可视化分析。结果 共纳入文献1736篇；中国、美国、日本是发文量最多的国家，发文机构主要来自中国高校，复旦大学是其中的主力军；UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS 杂志是发表肾癌预后研究最多的期刊；C反应蛋白、甲基化驱动基因、bap1和AKT等是近年来肾癌预后研究的方向；相关生物信息学研究将是未来的发展趋势。结论 肾癌预后研究覆盖方向广泛，生物标志物及生物信息学研究为该领域研究热点且有延续性爆发趋势；目前，我国发文量在肾癌预后研究领域处于领先地位，但国际合作较少，未来应加强跨国交流，产生更多创新性研究成果。相关临床工作者和科研人员可通过文献计量学分析准确、快速地掌握该领域的研究动态，为之后的研究和医疗实践打下坚实的基础。
Abstract:
Objective To analyze the literature distribution and development trend of renal cell carcinoma prognostic research in the world in recent ten years by bibliometrics.Methods The relevant literatures on the prognosis of renal cell carcinoma from 2011 to 2021 were searched in the Web of Science core collection database. Citespace5.8.R1 was used to visually display and analyze the number of papers, national distribution, research topics and high-frequency keywords.Results A total of 1736 literatures were retrieved. China, the United States and Japan were the countries with the largest number of publications. The publishing institutions were mainly from Chinese universities, and Fudan University was the main force. UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS was the most influential journal with the largest number of publications about prognosis of renal cell carcinoma. C-reactive protein, methylation driver gene, bap1 and AKT were the prognostic directions of renal cell carcinoma in recent years. Related bioinformatics research would be the development trend in the future.Conclusion Research on prognosis of renal cell carcinoma covers a wide range of directions, and biomarker and bioinformatics studies are hot spots in this field and have a continuous outbreak trend. At present, China is in the leading position in the field of prognosis of renal cell carcinoma in terms of published data, but there is little international cooperation. In the future, transnational exchanges should be strengthened to produce more innovative research results. Relevant clinical workers and researchers can accurately and quickly grasp the research trends in this field through bibliometrics analysis, and lay a solid foundation for future research and medical practice.

参考文献/References:

[1]周饶饶,戚聂聂,赵方正,等.舒尼替尼治疗晚期肾癌的预后因素分析及国际转移性肾细胞癌数据库联盟预后模型验证[J].现代泌尿外科杂志,2021,26(8):668-673.[2]Escudier B,Porta C,Schmidinger M,et al.Renal cell carcinoma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up[J].Ann Oncol,2019,30(5):706-720.[3]张连栋,王莉,李和程,等.男性肾癌进展与代谢相关指标及迟发性性腺功能减退症发生的关系[J].现代泌尿外科杂志,2019,24(3):210-213.[4]Barata PC,Rini BI.Treatment of renal cell carcinoma: Current status and future directions [J].CA Cancer J Clin,2017,67(6):507-524.[5]李凡,管维.肾癌诊疗相关进展 [J].临床外科杂志,2021,29(2):101-104.[6]Powell AG,Hughes DL,Wheat JR,et al.The 100 most influential manuscripts in gastric cancer: A bibliometric analysis[J].Int J Surg,2016,28:83-90.[7]Zhao Y,Huang L,Xiang M,et al.Trends in conjunctivochalasis research from 1986 to 2017:A bibliometric analysis[J].Medicine (Baltimore),2018,97(39):e12643.[8]Sun W,Huang P,Song H,et al.Bibliometric analysis of acute pancreatitis in Web of Science database based on CiteSpace software[J].Medicine (Baltimore),2020,99(49):e23208.[9]Ljungberg B,Bensalah K,Canfield S,et al.EAU guidelines on renal cell carcinoma:2014 update [J].Eur Urol,2015,67(5):913-924.[10]Zhu J,Liu W.Comparing like with like: China ranks first in SCI-indexed research articles since 2018[J].Scientometrics,2020,124:1691-1700.[11]李雯,姜仁贵,解建仓,等.基于文献计量学的城市洪涝灾害研究可视化知识图谱分析[J].西安理工大学学报,2020,36(4): 523-529.[12]Hizal M,Sendur MAN,Yasar HA,et al.Neutrophil-lymphocyte ratio as a prognostic factor for survival in patients with advanced renal cell carcinoma (Turkish Oncology Group Study)[J].J Oncol Pharm Pract,2020,26(7):1583-1589.[13]Ruiz-Sauri A,Garcia-Bustos V,Granero E,et al.Distribution of Vascular Patterns in Different Subtypes of Renal Cell Carcinoma.A Morphometric Study in Two Distinct Types of Blood Vessels[J].Pathol Oncol Res,2018,24(3):515-524.[14]Teishima J,Murata D,Hasegawa Y,et al.C-reactive protein can be used to predict the therapeutic effects of nivolumab in patients with metastatic renal cell carcinoma[J].Int J Urol,2019,26(11):1076-1077.[15]Wang J,Zhang Q,Zhu Q,et al.Identification of methylation-driven genes related to prognosis in clear-cell renal cell carcinoma[J].J Cell Physiol,2020,235(2):1296-1308.[16]Guo H,German P,Bai S,et al.The PI3K/AKT Pathway and Renal Cell Carcinoma[J].J Genet Genomics,2015,42(7):343-353.[17]Zhou Q,Qi Y,Wang Z,et al.CCR5 blockade inflames antitumor immunity in BAP1-mutant clear cell renal cell carcinoma[J].J Immunother Cancer,2020,8(1):1-8.

相似文献/References:

[1]熊波波,张劲松,王海峰,等.miRNAs与泌尿系肿瘤关系的研究进展[J].医学信息,2019,32(05):35.[doi:10.3969/j.issn.1006-1959.2019.04.013]
　XIONG Bo-bo,ZHANG Jin-song,WANG Hai-feng,et al.Research Progress on the Relationship between miRNAs and Urinary Tumors[J].Journal of Medical Information,2019,32(15):35.[doi:10.3969/j.issn.1006-1959.2019.04.013]
[2]刘佳生.后腹腔镜根治术对肾癌患者ACTH、Cor水平的影响[J].医学信息,2020,33(10):124.[doi:10.3969/j.issn.1006-1959.2020.10.035]
　LIU Jia-sheng.The Effect of Retroperitoneal Laparoscopic Radical Operation on ACTH and Cor[J].Journal of Medical Information,2020,33(15):124.[doi:10.3969/j.issn.1006-1959.2020.10.035]
[3]刘佳生.腹腔镜下保留肾单位手术对肾癌患者sCD44v6、sICAM-1、β-EP水平的影响[J].医学信息,2020,33(14):117.[doi:10.3969/j.issn.1006-1959.2020.14.035]
　LIU Jia-sheng.Effect of Laparoscopic Nephron-sparing Operation on the Levels of sCD44v6,sICAM-1 and β-EP in Patients with Renal Cell Carcinoma[J].Journal of Medical Information,2020,33(15):117.[doi:10.3969/j.issn.1006-1959.2020.14.035]

更新日期/Last Update: 1900-01-01